Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Kahn

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
The New England Journal of Medicine|June 23, 2001
Expenditures for the care of patients with HIVJ G Kahn
American Journal of Public Health|December 1, 1996
The cost-effectiveness of HIV prevention targeting: how much more bang for the buck?J G Kahn
Medicare Brief|January 19, 2002
Coordination of health coverage for Medicare enrollees: living with HIV/AIDS in CaliforniaJ Eichner, J G Kahn
AIDS (London, England)|January 11, 2000
Fighting global AIDS: the value of cost-effectiveness analysisJ G Kahn, E Marseille
AIDS & Public Policy Journal|April 1, 1997
The role of cost-effectiveness analysis in assessing HIV-prevention interventionsJ G Kahn, K C Sanstad
Journal of General Internal Medicine|July 18, 2013
Capsule commentary on Long and Stavert, portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysisJ G Kahn, E A Marseille
JAMA|September 9, 1992
Consumer choices and the American health care systemJ G Kahn, P Lurie, K Grumbach
AIDS (London, England)|June 19, 1998
Cost-effectiveness of antiviral drug therapy to reduce mother-to-child HIV transmission in sub-Saharan AfricaE Marseille, J G Kahn, J Saba
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1995
HIV risk adjustment: issues and proposed approachesJ G Kahn, H Luft, M D Smith
JAMA|July 22, 1992
Regulation of benzodiazepine prescriptionP Lurie, J G Kahn, S M Wolfe
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
The New England Journal of Medicine|June 23, 2001
Expenditures for the care of patients with HIVJ G Kahn
American Journal of Public Health|December 1, 1996
The cost-effectiveness of HIV prevention targeting: how much more bang for the buck?J G Kahn
Medicare Brief|January 19, 2002
Coordination of health coverage for Medicare enrollees: living with HIV/AIDS in CaliforniaJ Eichner, J G Kahn
AIDS (London, England)|January 11, 2000
Fighting global AIDS: the value of cost-effectiveness analysisJ G Kahn, E Marseille
AIDS & Public Policy Journal|April 1, 1997
The role of cost-effectiveness analysis in assessing HIV-prevention interventionsJ G Kahn, K C Sanstad
Journal of General Internal Medicine|July 18, 2013
Capsule commentary on Long and Stavert, portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysisJ G Kahn, E A Marseille
JAMA|September 9, 1992
Consumer choices and the American health care systemJ G Kahn, P Lurie, K Grumbach
AIDS (London, England)|June 19, 1998
Cost-effectiveness of antiviral drug therapy to reduce mother-to-child HIV transmission in sub-Saharan AfricaE Marseille, J G Kahn, J Saba
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 1, 1995
HIV risk adjustment: issues and proposed approachesJ G Kahn, H Luft, M D Smith
JAMA|July 22, 1992
Regulation of benzodiazepine prescriptionP Lurie, J G Kahn, S M Wolfe
Pageof 4